AHA press release announcing new monitoring guidelines for patients undergoing hormonal therapies who are at high risk of cardiovascular complications.

Drug attrition during pre-clinical and clinical development:
Understanding and managing drug-induced cardiotoxicity

A review of the impact of drug-induced cardiotoxicity on drug development, from early-phase through post-market.

DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling

A reference list of 1318 FDA-approved drugs ranked by cardiotoxicity according to FDA labeling.

European Society of Cardiology Press Release (2024)

European Society of Cardiology press release highlighting the growing need for detecting and monitoring cardiovascular side effects caused by cancer therapy.

Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?:
An English Retrospective Cohort Study

Retrospective cohort study of 104,028 adults to determine when cardiovascular mortality overtakes cancer-specific mortality during survivorship.

Cardiotoxicity following thoracic radiotherapy for lung cancer

An article examining the risk, unmet needs, and future directions of cardiovascular toxicity due to radiotherapy treatments for lung cancer.

Precision cardio-oncology: Understanding the cardiotoxicity of cancer therapy

A review of the broad range of cardiotoxicity caused by different classes of cancer therapies, existing screening options, and the growing need for cardio-oncology solutions.

Cardiac events among a cohort of 17,389 patients receiving cancer chemotherapy:
Short and long term implications

Retrospective analysis of the incidence of cardiovascular disease in patients receiving cancer chemotherapy.